May 14, 2020 / 11:44 AM / 11 days ago

BRIEF-Adaptimmune Therapeutics Reports Qtrly Loss Per Share $0.04

May 14 (Reuters) - Adaptimmune Therapeutics PLC:

* ADAPTIMMUNE REPORTS Q1 FINANCIAL RESULTS

* ADAPTIMMUNE THERAPEUTICS PLC - FUNDED INTO 2H 2021

* ADAPTIMMUNE THERAPEUTICS PLC SEES AS OF MARCH 31, 2020, ADAPTIMMUNE HAD CASH AND CASH EQUIVALENTS OF $86.4 MILLION

* ADAPTIMMUNE THERAPEUTICS PLC QTRLY LOSS PER SHARE $0.04 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below